PharmAbcine Inc., a clinical-stage biotech company focusing on the development of next generation antibody therapeutics, announced it has dosed the first patient in its...
EOFlow Co., Ltd., a provider of wearable drug delivery solutions, has announced that its wholly owned US subsidiary, EOFlow Inc. has signed an agreement...
Soin Therapeutics, a biotechnology company based in Dayton, OH, has completed the formulation development work of their novel, proprietary low dose naltrexone pill to...
WuXi Biologics, a global company with leading open-access biologics technology platforms, and ImmuneOncia Therapeutics, Inc., a clinical-stage, immuno-oncology company in South Korea, announced that...
